Genital Diseases, Male  >>  hydrocortisone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00006371: A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Terminated
2
2
US
aminoglutethimide, Cytadren, ketoconazole, Nizoral, therapeutic hydrocortisone, corticosteroid
H. Lee Moffitt Cancer Center and Research Institute, National Cancer Institute (NCI), Janssen Pharmaceuticals
Prostate Cancer
12/01
12/01
NCT00181597: Trilostane for Androgen-Independent Prostate Cancer

Completed
2
24
US
Trilostane, Hydrocortisone
Genzyme, a Sanofi Company
Prostate Cancer, Prostate Adenocarcinoma
01/06
01/06
NCT00447473: Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer

Terminated
2
31
US
GM-CSF, Leukine, Ketoconazole, Nizoral, Extina, Xolegel, Kuric, Mitoxantrone, Novantrone, Mitoxantrone
The Methodist Hospital Research Institute, Bayer
Prostatic Neoplasms
08/08
09/08
NCT00298155: Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

Completed
2
35
US
goserelin with dutasteride, goserelin with bicalutamide and dutasteride, goserelin with bicalutamide and dutasteride and ketoconazole
University of Washington, GlaxoSmithKline, AstraZeneca
Cancer, Prostate Neoplasms
06/10
01/14
NCT00953576: Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Terminated
1/2
11
US
ketoconazole, Nizoral, hydrocortisone, Cortef, Hydrocortone, dutasteride, Avodart, lapatinib, lapatinib ditosylate, Tyverb
Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Massachusetts General Hospital, Prostate Cancer Foundation Clinical Research Consortium, GlaxoSmithKline
Prostate Cancer
04/13
04/13

Download Options